USPTO serial 76353143
SITE-DIRECTED DRUG DISCOVERY
Reviewed by CopyMark Law Group
Reg. 2768762Status 710
- Filing date
- Status date
- Registration date
- Sep 30, 2003
- Examiner
- BELL, MARLENE D
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SITE-DIRECTED DRUG DISCOVERY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Copenhagen, DK
Copenhagen, DK
Copenhagen, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrea A. Jacobs
PETER F CORLESS EDWARDS & ANGELL LLPPO BOX 55874BOSTON, MA 02205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for industrial, scientific, agricultural, horticultural and forestry purposes, namely, drug products and drug discovery tools in the nature of biological target molecules and ligands for biological target molecules, chemical reagents, chemical preparations and compositions, namely, chemical chelators, chemical chelates, biological reagents, biological preparations or compositions, chemical and biological substances, namely biological substances, isolated gene and amino and sequences, cell membranes and cells incorporating amino acid sequences, and the use thereof for identifications of ligands, including ligands that may be developed into drugs for analytical purposes, test substances, namely proteinaceous compounds and chemicals, small molecules, namely, chemical reagents used for drug screening and validation of potential drug targets | SECTION 8 - CANCELLED | — |
| 042 | Scientific and industrial research, namely research and development of medicines, pharmaceutical, veterinary or cosmetic preparations or compositions, the studying of receptors, chemical analysis and research, namely pharmaceutical screening assays and other bioaffinity assays, pre-synthetic drug design, molecular modeling, chemical synthesis | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 7TM Pharma A/S
- Other trademarks owned by 7TM Pharma A/S
- Other trademarks owned by 7TM Pharma A/S
- Other trademarks in Class 001
- Other trademarks in Class 042
- Similar marks named SITE-DIRECTED DRUG DISCOVERY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2010 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 16, 2008 | CFIT | CASE FILE IN TICRS | — |
| Feb 17, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 30, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 18, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 30, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Apr 16, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 27, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 25, 2003 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 6, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2003 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2002 | PAPER RECEIVED | — | |
| Oct 2, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2002 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 3, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2002 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |